Springer Nature and UC Strike Largest Open-Access Deal in US

The agreement will include approximately 2,700 journals as well as plans to transition Nature journals to open access for the University of California system.

| 4 min read
geisel library uc university of california san diego ucsd springer nature transformative deal open access publishing

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ABOVE: Geisel Library at the University of California, San Diego
© ISTOCK.COM, INNAPOKA

Update (July 27, 2022): Springer Nature and the University of California announced today that they have extended their original agreement through 2024, and that it will now include Nature journals as well as the rest of Springer Nature's portfolio.

Today (June 16), the University of California and the academic publisher Springer Nature announced that they had forged the largest open-access deal in North America to date.

“We’re quite delighted about this agreement, because we think it is very significant,” says Ivy Anderson, the associate executive director of the California Digital Library and co-chair of UC’s publisher negotiation team. “It shows that a large, research-intensive institution can sign an agreement with a large publisher for open access and make that successful.”

Over the last few years, universities and research institutions around the world have been pushing publishers for agreements ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Diana Kwon

    Diana is a freelance science journalist who covers the life sciences, health, and academic life.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide